Li Keqiang chaired an executive meeting of the State Council to deploy and promote innovation and upgrading of the pharmaceutical industry

Premier Li Keqiang chaired an executive meeting of the State Council on February 14 to deploy and promote innovation and upgrading of the pharmaceutical industry to better serve the people's livelihood and stabilize growth; determine measures to further promote the development of traditional Chinese medicine and give full play to the advantages of traditional medicine to benefit the people; and decided to carry out innovative development of service trade Pilot projects to promote the transformation of foreign trade and enhance the competitiveness of the service industry.
  Premier Li Keqiang chaired an executive meeting of the State Council on February 14 to deploy and promote innovation and upgrading of the pharmaceutical industry to better serve the people's livelihood and stabilize growth; determine measures to further promote the development of traditional Chinese medicine and give full play to the advantages of traditional medicine to benefit the people; and decided to carry out innovative development of service trade Pilot projects to promote the transformation of foreign trade and enhance the competitiveness of the service industry.

The meeting pointed out that the pharmaceutical industry is related to the health of all people, has huge market demand, and is an important industry in all countries. Combining the reform of the medical and health system and accelerating the development of my country's pharmaceutical industry are of great significance to better meet the people's medical and health care needs, promote the construction of a healthy China, and release economic growth potential. The meeting determined that the first step is to target the urgent needs of the public, strengthen research and innovation of original drugs, first generic drugs, traditional Chinese medicines, new preparations, high-end medical devices, etc., and accelerate the industrialization of major drugs for frequently-occurring and rare diseases such as tumors, diabetes, cardiovascular and cerebrovascular diseases. Support the international registration and certification of patented domestic original drugs and branded generic drugs. The second is to improve the safety evaluation and product traceability system, strengthen the whole-process quality supervision, benchmark against international advanced levels, and implement actions to improve the standards of drugs and medical devices, especially to improve the quality of essential drugs. Explore the implementation of compulsory commercial insurance for product quality and safety. Promote the intelligent and green transformation of pharmaceutical production processes. The third is to combine the reform of medical treatment, medical insurance, and pharmaceutical linkage to speed up the review and approval of urgently needed clinical drugs and medical device products. Improve fiscal, taxation, pricing, government procurement and other policies, and explore ways to use industrial funds to support pharmaceutical industrialization and new product promotion. Support the mergers and reorganizations of pharmaceutical companies, cultivate leading companies, and solve the problem of "small fragmentation" in the industry. The fourth is to build a modern pharmaceutical distribution network covering both urban and rural areas and gradually rationalize the prices of pharmaceutical consumables. Build a national drug information public service platform, disclose price, quality and other information, and accept public supervision.

The meeting pointed out that inheriting the advantages of traditional Chinese medicine and giving full play to its unique role can better benefit human health. The meeting determined that, first, we must promote the inheritance, protection and exploration of traditional Chinese medicine and ethnic medicine, rescue rare and valuable ancient books and documents that are on the verge of being lost, strengthen teacher-to-teacher education, vigorously cultivate traditional Chinese medicine talents, and improve the emergency treatment, disease prevention and treatment capabilities of traditional Chinese medicine. Second, we must promote the integration of traditional Chinese and Western medicine and explore the use of modern technology and industrial models to accelerate the development of traditional Chinese medicine. Strengthen the prevention and treatment of major difficult diseases, chronic diseases and other traditional Chinese medicine and the research and development of new drugs. Improve the standard system of traditional Chinese medicine, strengthen the protection and utilization of traditional Chinese medicine resources and standardize their cultivation. Third, we must relax access to traditional Chinese medicine services, improve the traditional Chinese medicine service network covering urban and rural areas, and ensure that social and government-run traditional Chinese medicine medical institutions enjoy equal rights in practice and other aspects. Fourth, we must develop traditional Chinese medicine health care services, promote the integrated development of traditional Chinese medicine, health care, tourism and culture, and promote "Internet +" traditional Chinese medicine. Fifth, we must increase investment and policy support for traditional Chinese medicine. Increase the number of varieties of Chinese patent medicines in the National Essential Medicines List to better play the role of “guaranteing the basics”. Strengthen the research and promotion of traditional Chinese medicine concepts and expand the international trade, dissemination and popularization of traditional Chinese medicine.

The meeting believed that expanding opening up is an important measure to promote economic development and upgrading. In the current complex and severe international economic situation, it is even more important to persist in improving the level of opening up to the outside world. While promoting the development of trade in goods, accelerating the development of trade in services can promote the optimization of foreign trade structure, cultivate new economic drivers and drive employment. The meeting decided to use 2 years to develop 10 provinces and cities in Tianjin, Shanghai, Hainan, Shenzhen, Hangzhou, Wuhan, Guangzhou, Chengdu, Suzhou, and Weihai and 5 cities in Harbin, Jiangbei, Liangjiang, Gui'an, and Xixian The ***** New District has launched a pilot program for the innovative development of service trade, focusing on exploring the system construction in eight aspects including service trade management system, development model, and facilitation, and orderly expanding open access to the service industry. To this end, relevant policy support must be increased. First, we must promote preferential tax policies for technologically advanced service enterprises in pilot areas, expand the scope of enterprises enjoying the policy from service outsourcing to other high-tech, high value-added service industries, and provide a 15% reduction in corporate income tax, and The portion of employee education funds that does not exceed 8% of total wages and salaries shall be deducted before tax. Second, we must establish a service trade innovation development guidance fund to provide financing support for small and medium-sized service enterprises in pilot areas. Financial discounts will be provided to pilot areas for importing research and development, design, energy conservation, environmental protection and environmental services that are urgently needed domestically. Third, we must encourage financial institutions to innovate in supply chain financing and other businesses, and fully implement bonded supervision of service outsourcing for identified technologically advanced service enterprises in pilot areas.

The meeting also studied other matters.